Abstract: The demulsifying cleaning of metallic surfaces which may be contaminated with oil(s) with at least one further nonpolar organic compound, with fat(s), with soap(s), with particulate dirt or with at least one anionic organic compound using an aqueous, alkaline, surfactant-containing bath solutions.

Abstract: The demulsifying cleaning of metallic surfaces which may be contaminated with oil(s) with at least one further nonpolar organic compound, with fat(s), with soap(s), with particulate dirt or with at least one anionic organic compound using an aqueous, alkaline, surfactant-containing bath solutions.

Abstract: The demulsifying cleaning of metallic surfaces which may be contaminated with oil(s) with at least one further nonpolar organic compound, with fat(s), with soap(s), with particulate dirt or with at least one anionic organic compound using an aqueous, alkaline, surfactant-containing bath solutions.

Abstract: The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use.

Abstract: The demulsifying cleaning of metallic surfaces which may be contaminated with oil(s) with at least one further nonpolar organic compound, with fat(s), with soap(s), with particulate dirt or with at least one anionic organic compound using an aqueous, alkaline, surfactant-containing bath solutions.

Abstract: A method for treating or pre-treating parts, profiled-pieces, strips, sheet metals or wires having metallic surfaces, in which at least 5% of these surfaces consists of aluminum or of at least one aluminum alloy with an acid aqueous solution which contains fluoride, zinc and phosphate and which has the following dissolved contents in the phosphatizing solution: sodium virtually none, from 0.04 to less than 2 g/L; potassium virtually none or in a concentration ranging from 0.025 to 2.5 g/L; sodium and potassium in a concentration ranging from 0.025 to 2.5 g/L as sodium, whereby the potassium content is converted to sodium on a molar basis; zinc 0.2 to 4 g/L zinc, 5 to 65 g/L calculated as PO4; 0.03 to 0.5 g/L phosphate free fluoride wherein the total fluoride is present in a concentration ranging from 0.1 to 5 g/L. A zinc-containing phosphate layer is thereby deposited onto the metallic surfaces with a layer weight ranging from 0.5 to 10 g/m2.

Abstract: The demulsifying cleaning of metallic surfaces which may be contaminated with oil(s) with at least one further nonpolar organic compound, with fat(s), with soap(s), with particulate dirt or with at least one anionic organic compound using an aqueous, alkaline, surfactant-containing bath solutions.

Abstract: Provided are compounds of the formula (I): or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.

Abstract: A method for treating or pre-treating parts, profiled-pieces, strips, sheet metals or wires having metallic surfaces, in which at least 5% of these surfaces consists of aluminum or of at least one aluminum alloy with an acid aqueous solution which contains fluoride, zinc and phosphate and which has the following dissolved contents in the phosphatizing solution: sodium virtually none, from 0.04 to less than 2 g/L; potassium virtually none or in a concentration ranging from 0.025 to 2.5 g/L; sodium and potassium in a concentration ranging from 0.025 to 2.5 g/L as sodium, whereby the potassium content is converted to sodium on a molar basis; zinc 0.2 to 4 g/L zinc, 5 to 65 g/L calculated as PO4; 0.03 to 0.5 g/L phosphate free fluoride wherein the total fluoride is present in a concentration ranging from 0.1 to 5 g/L. A zinc-containing phosphate layer is thereby deposited onto the metallic surfaces with a layer weight ranging from 0.5 to 10 g/m2.

Abstract: A computing environment and techniques are provided for processing work out of order in one or more processing contexts. The processing techniques include: determining, for a processing context having an associated stack of waiting resources, whether a last-in listed resource in the stack of waiting resource is available, and if so, resuming processing of a suspended unit of work requiring the last-in listed resource; and determining, otherwise, whether an out of order execution unit of work is available for processing in the context, and if so, processing the out of order execution unit of work while the suspended unit of work awaits the last-in listed resource. Out of order execution units of work can be processed in order from a regular unit of work queue, or out of order from an out of order unit of work queue of a processing context.

Abstract: The demulsifying cleaning of metallic surfaces which may be contaminated with oil(s) with at least one further nonpolar organic compound, with fat(s), with soap(s), with particulate dirt or with at least one anionic organic compound using an aqueous, alkaline, surfactant-containing bath solutions.

Abstract: The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use.

Abstract: Provided are compounds of the formula (I): or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.

Abstract: Compounds are provided containing purine nucleotides that bear moieties X at the 2? position thereof wherein X is R1—(R2)n; R1 is C3-C20 alkyl, C4-C20 alkenyl or C2-C20 alkynyl; R2 is halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, amino, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, or a group that enhances the pharmacokinetic properties of oligonucleotides; and n is an integer from 0 to about 6. Such compounds are useful for modulating the synthesis of proteins.

Abstract: The invention relates to a method for treating or pre-treating parts, profiled-pieces, strips, sheet metals and/or wires having metallic surfaces, in which at least 5% of these surfaces consists of aluminum and/or of at least one aluminum alloy and, optionally, the remaining metallic surfaces can predominantly consist of iron alloys, zinc and/or zinc alloys. The treatment involves the use of an acid aqueous solution, which contains fluoride, zinc and phosphate and which has the following dissolved contents in the phosphatizing solution: sodium virtually none or in a concentration ranging from 0.04 to less than 2 g/L; potassium virtually none or in a concentration ranging from 0.025 to 2.5 g/L; sodium and potassium in a concentration ranging from 0.025 to 2.5 g/L as sodium, whereby the potassium content is converted to sodium on a molar basis; zinc in a concentration ranging from 0.

Abstract: Novel 2′-O-alkyl guanosine compounds are provided.

Abstract: The present invention provides novel compounds of Formula (I), its prodrug forms, or pharmaceutically acceptable salts thereof. The compounds of this invention are inhibitors of serine proteases, Urokinase (uPA), Factor Xa (FXa), and/or Factor VIIa (FVIIa), and have utility as anti cancer agents and/or as anticoagulants for the treatment or prevention of thromboembolic disorders in mammals. The present invention also provides a process for the selective acylation of an amino group.

Abstract: The present invention provides novel compounds of Formula I: 1

Abstract: Processes for preparing 2′-O-alkylated guanosine, uridine, cytidine, and 2,6-diaminopurine 3′-O-phosphoramidites include the steps of alkylating nucleoside precursors, adding suitable blocking groups and phosphitylating. For the guanosine 2′-O-alkylated 3′-O-phosphoramidites, alkylation is effected on 2,6-diamino-9-(&bgr;-D-ribofuranosyl) purine followed by deamination. For uridine 2′-O-alkylated 3′-O-phosphoramidites, alkylation is effect on a dialkyl stannylene derivative of uridine. For cytidine 2′-O-alkylated 3′-O-phosphoramidites, alkylation is effected directly on cytidine. Alkylation is effected directly upon 2,6-diaminopurine.

Abstract: Processes for preparing 2'-O-alkylated guanosine, uridine, cytidine, and 2,6-diaminopurine 3'-O-phosphoramidites include the steps of alkylating nucleoside precursors, adding suitable blocking groups and phosphitylating. For the guanosine 2'-O-alkylated 3'-O-phosphoramidites, alkylation is effected on 2,6-diamino-9-(.beta.-D-ribofuranosyl)purine followed by deamination. For uridine 2'-O-alkylated 3'-O-phosphoramidites, alkylation is effect on a dialkyl stannylene derivative of uridine. For cytidine 2'-O-alkylated 3'-O-phosphoramidites, alkylation is effected directly on cytidine. Alkylation is effected directly upon 2,6-diaminopurine.